A Study to Determine Final Geriatric Assessment in Haematology (GAH) Score as a Tool for Predicting Tolerance to Treatment in Elderly Patients (≥ 65 Years) With Haematologic Neoplasms

NCT02842229 · clinicaltrials.gov ↗

COMPLETED

Status

117

Enrollment

INDUSTRY

Sponsor class

Conditions

Myelodysplastic Syndromes
Leukemia Myeloid Acute
Multiple Myeloma
Leukemia, Lymphocytic, Chronic, B-Cell

Sponsor

Celgene